Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-07 Purchase | 2023-11-09 8:32 pm | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) | View |
| 2023-08-14 Sale | 2023-08-15 5:45 pm | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 1,241 | $138.16 | $171,455 | 20,946 (Direct) | View |
| 2023-02-06 Purchase | 2023-02-08 7:32 pm | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) | View |
| 2022-11-22 Sale | 2022-11-25 9:33 pm | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 6,974 | $150.45 | $1,049,264 | 19,112 (Indirect Direct) | View |
| 2022-08-08 Sale | 2022-08-09 6:12 pm | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 1,089 | $152.33 | $165,883 | 26,086 (Indirect Direct) | View |
| 2022-04-19 Purchase | 2022-04-21 6:04 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,355,000 | $3.69 | $4,999,950 | 4,174,379 (Indirect) | View |
| 2022-02-10 Purchase | 2022-04-05 07:22 am | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) | View |
| 2022-02-02 Purchase | 2022-02-02 9:25 pm | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 175,000 | $27 | $4,725,000 | 2,139,771 (Indirect) | View |
| 2021-07-19 Purchase | 2021-07-20 9:39 pm | RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Longitude Prime Partners LLC Longitude Prime Fund L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 150,000 | $20 | $3,000,000 | 779,032 (Indirect) | View |
| 2021-05-18 Purchase | 2021-05-18 8:14 pm | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) | View |
| 2021-05-11 Purchase | 2021-05-11 8:29 pm | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 235,000 | $17 | $3,995,000 | 3,220,775 (Indirect) | View |
| 2020-11-12 Sale | 2020-11-13 4:56 pm | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 9,929 | $146.72 | $1,456,738 | 20,368 (Direct) | View |
| 2020-10-20 Purchase | 2020-10-22 8:24 pm | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner | 233,333 | $18 | $4,199,994 | 3,918,691 (Direct) | View |
| 2020-08-28 Sale | 2020-09-01 7:33 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 3,496 | $10.75 | $37,568 | 3,202,530 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-28 6:20 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 625,000 | $16 | $10,000,000 | 2,819,379 (Indirect) | View |
| 2020-07-10 Purchase | 2020-07-14 8:11 pm | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 109,090 | $27.5 | $2,999,975 | 2,600,877 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-07 Conversion | 2023-11-09 8:32 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 24,018,702 | $0 | 2,567,100 (Indirect) | View |
Ownership | 2023-11-02 9:36 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 2,067,743 (Indirect) | View |
| 2023-08-11 Option Award | 2023-08-15 5:45 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 3,075 | $0 | 20,946 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:12 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-08-05 Option Award | 2022-08-09 6:12 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 2,561 | $0 | 26,086 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 4:30 pm | N/A 2032-05-25 | Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:13 pm | N/A 2032-05-23 | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 9,925 | $0 | 9,925 (Direct) | View |
| 2022-04-27 Other | 2022-04-29 7:07 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 2,155,801 | $0 | 2,163,816 (Indirect) | View |
| 2022-01-25 Exercise | 2022-01-27 9:23 pm | 2020-01-22 2022-04-10 | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,964,576 | $13.2 | 1,964,771 (Indirect) | View |
| 2021-08-18 Option Award | 2021-08-20 7:12 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 2,000 | $137.75 | 24,614 (Indirect) | View |
| 2021-07-29 Option Award | 2021-08-02 6:10 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 2,246 | $0 | 22,614 (Direct) | View |
| 2021-07-19 Conversion | 2021-07-20 9:39 pm | N/A N/A | RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Longitude Prime Partners LLC Longitude Prime Fund L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 23,838,431 | $0 | 779,032 (Indirect) | View |
Ownership | 2021-07-14 7:35 pm | N/A N/A | RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 6,558,675 (Indirect) | View |
| 2021-05-27 Option Award | 2021-06-01 4:31 pm | N/A 2031-05-26 | Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-05-18 Conversion | 2021-05-18 8:14 pm | N/A N/A | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 2,187,504 | $0 | 3,096,594 (Indirect) | View |
| 2021-05-13 Option Award | 2021-05-17 8:36 pm | N/A 2031-05-12 | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 9,925 | $0 | 9,925 (Direct) | View |
Ownership | 2021-05-13 7:18 pm | N/A N/A | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 0 | $0 | 2,187,504 (Indirect) | View |
| 2021-05-11 Conversion | 2021-05-11 8:29 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 5,971,550 | $0 | 3,220,775 (Indirect) | View |
Ownership | 2021-05-06 9:25 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 2,985,775 (Indirect) | View |
| 2021-04-14 Other | 2021-04-15 9:00 pm | N/A N/A | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. Longitude Capital Partners IV LLC ENRIGHT PATRICK G 10% Owner | 1,005,012 | $0 | 3,928,715 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 4:31 pm | N/A 2030-12-30 | Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director | 8,149 | $2.224 | 8,149 (Direct) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 855,944 | $0 | 856,835 (Indirect) | View |
| 2020-11-02 Exercise | 2020-11-04 7:26 pm | 2020-11-02 2020-11-02 | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 9,929 | $0 | 30,297 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 8:24 pm | N/A N/A | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner | 3,685,358 | $0 | 3,918,691 (Direct) | View |
Ownership | 2020-10-15 9:55 pm | N/A N/A | Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G 10% Owner | 0 | $0 | 3,685,358 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 11,432 | $14.6 | 0 (Direct) | View |
| 2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 162,258 | $34.5 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 19,755 | $19.1 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 7,840 | $34.5 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 7,500 | $1.71 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 17,500 | $16.24 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 15,398 | $17.39 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 65,849 | $34.36 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 52,421 | $28.21 | 0 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 3:05 pm | N/A 2030-09-29 | Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director | 8,379 | $2.163 | 8,379 (Direct) | View |
| 2020-09-21 Other | 2020-09-23 9:35 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 6,204,831 | $0 | 6,374,929 (Indirect) | View |
| 2020-08-06 Option Award | 2020-08-10 4:42 pm | N/A 2030-08-05 | Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director | 9,470 | $0 | 27,133 (Direct) | View |
| 2020-07-28 Conversion | 2020-07-28 6:20 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 18,592,979 | $0 | 2,819,379 (Indirect) | View |
Ownership | 2020-07-23 9:26 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 2,194,379 (Indirect) | View |
| 2020-06-30 Option Award | 2020-07-02 4:06 pm | N/A 2030-06-29 | Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director | 5,436 | $2.677 | 5,436 (Direct) | View |